London, United Kingdom · Founded 2020 · Privately Held (backing)
Developer of kidney-targeted gene therapy products intended for the treatment of chronic glomerular kidney diseases, including rare inherited and non-genetic conditions. Purespring Therapeutics is based in London, United Kingdom and was founded in 2020. Its last known valuation is $81.6 million. It has raised $165 million.
These 6 firms already write checks for companies like Purespring Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.